Replies to post #72093 on Biotech Values

[genisi]

Re: Cladribine for MS

Perhaps because J&J tried developing oral Cladribine for MS but failed and returned the rights to Scripps, when Ivax licensed the drug and entered into a co development agreement with Merck Serono, Frost was able to get a better deal.